US2002128249A1PendingUtilityA1

Phthalocyanine analogs

Assignee: QINETIQ LTDPriority: Oct 30, 1997Filed: Jan 4, 2002Published: Sep 12, 2002
Est. expiryOct 30, 2017(expired)· nominal 20-yr term from priority
Inventors:Michael J. Cook
B82Y 10/00C07D 487/22C09B 47/00A61P 43/00A61P 35/00B82Y 30/00C09K 19/3488
40
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Disclosed are compounds of formula V where M is a metal atom; a metal compound; 2H whereby one H is bonded to each of the two nitrogen atoms depicted as being bonded to M (positions 29 and 31 shown) R 3 is H or methyl; R 1 and R 4 are independently selected from: H, C 1 to C 4 alkyl, C 2 to C 4 alkenyl, methoxy, butoxy, propoxy, NH 2 , NH—(C 1 to C 4 alkyl), N—(C 1 to C 4 alkyl) 2 , S—(C 1 to C 4 alkyl); R 8 to R 25 are the same or different and are independently selected from: C 1 to C 32 alkyl; C 2 to C 32 alkenyl; X—O—Y; X-phenyl, X 2 COOX 1 , X 2 CONR 1 R 11 , H; halide; where: X and X 2 are independently selected from: a chemical bond, —(CH 2 ) n — where n is an integer from 1 to 32, —(CH 2 ) a —CH═CH(CH 2 ) b where a and b are independently selected from integers 0-32 and a+b totals 32; X 1 and Y are independently selected from: C 1 to C 32 alkyl, C 2 to C 32 alkenyl, and H; R 1 and R 11 are independently selected from: H; C 1 to C 32 alkyl, C 2 to C 32 alkenyl, —(CH 2 ) n —; with the proviso that at least one of R 8 to R 25 is selected from: C 1 to C 32 alkyl, C 2 to C 32 alkenyl, X—O—Y, X-phenyl, X 2 COOX 1 , X 2 CONR 1 R 11 .

Claims

exact text as granted — not AI-modified
1 . A compound of Formula I (FIG. 1( b ))  
       wherein: 
 M is selected from: 
 a metal atom; a metal compound; 2H whereby one H is bonded to each of the two nitrogen atoms depicted as being bonded to M (positions 29 and 31 shown)  
 and wherein:  
 
 one or more of the Q groups is selected from: formula II (FIG. 1( c )) or formula III (FIG. 1( d )), with the remaining Q groups each being formula IV (FIG. 1( e )):  
 wherein:  
 R 33  and R 34  are independently selected from: H or methyl  
 R 35  is selected from: H; C 1  to C 4  alkyl; C 2  to C 4  alkenyl: methoxy: butoxy; propoxy; NH 2 ; NH—(C 1  to C 4  alkyl); N—(C 1  to C 4  alkyl) 2 , S—(C 1  to C 4  alkyl),  
 each R n  and R p  group is independently selected from: C 1  to C 32  alkyl; C 2  to C 32  alkenyl; X—O—Y; X-phenyl  
 X 2 COOX 1 ; X 2 CONR 1 R 11 ; H; halide  
 wherein:  
 X and X 2  are independently selected from: a chemical bond; —(CH 2 ) n — wherein n is an integer from 1 to 32; —(CH 2 ) a —CH═CH(CH 2 ) b  where a and b are independently selected from integers 0-32 and a+b totals 32.  
 X 1  and Y are independently selected from: C 1  to C 32  alkyl; C 2  to C 32  alkenyl; H  
 R 1  and R 11  are independently selected from: H; C 1  to C 32  alkyl; C 2  to C 32  alkenyl; —(CH 2 ) n — 
 with the proviso that where more than one Q is Formula II with the remaining Q group being Formula IV, at least one group independently selected from: R 33,  R 34 , R 35 , an R n  group, an R p  group, is not H.  
 
     
     
         2 . A compound as claimed in  claim 1  having formula V (FIG. 1( f )),  
       Wherein: 
 M is selected from: 
 a metal atom, a metal compound: 2H whereby one H is bonded to each of the two nitrogen atoms depicted as being bonded to M (positions 29 and 31 shown)  
 
 R 3  is H or methyl  
 R 1  and R 4  are independently selected from: H; C 1  to C 4  alkyl; C 2  to C 4  alkenyl; methoxy; butoxy; propoxy; NH 2 ; NH—(C 1  to C 4  alkyl); N—(C 1  to C 4  alkyl) 2 , S—(C 1  to C 4  alkyl),  
 R 8  to R 25  are the same or different and are independently selected from: 
 C 1  to C 32  alkyl; C 2  to C 32  alkenyl; X—O—Y; X-phenyl  
 X 2 COOX 1 ; X 2 CONR 1 R 11 ; H; halide  
 and wherein X, X 2 , X 1 , Y, R 1  and R 11  are as defined in  claim 1 .  
 
 
     
     
         3 . A compound as claimed in  claim 1  or  claim 2  wherein all non-peripheral R groups other than those attached to pyridyl nuclei are selected from: H; alkyl containing up to 32; up to 20; between 4-14; or between 8-12 C atoms where 1 or more adjacent CH 2  groups may be replaced by O or a double bond, and the remaining R groups are all H.  
     
     
         4 . A compound as claimed in  claim 3  wherein all non-peripheral R groups are H.  
     
     
         5 . A compound as claimed in any one of the preceding claims wherein all peripheral R groups other than those attached to pyridyl nuclei are selected from: alkyl containing up to 32; up to 20; between 4-14; between 8-12 C atoms, and the remaining R groups are all H.  
     
     
         6 . A compound as claimed in any one of the preceding claims wherein R 33,  R 34 , R 1  and R 3 are H.  
     
     
         7 . A compound as claimed in any one of the preceding claims wherein R 35  and R 4  are electron donating groups independently selected from: O-alkyl, NH 2 , NH-alkyl, N(alkyl) 2 , alkyl, S-alkyl.  
     
     
         8 . A compound as claimed in any one of the preceding claims wherein those the alkyl groups present within R groups are straight chain alkyl.  
     
     
         9 . A compound as claimed in any one of the preceding claims wherein M is selected from: 2H; Ru, Ni, Pb, V, Pd, Co, Nb, Al, Sn, Zn, Cu, Mg, Ca, In, Ga, Fe, Eu, Lu and Ge.  
     
     
         10 . A compound as claimed in  claim 9  wherein M is selected from: 2H; Zn; Cu; Co; Ru; and Ni.  
     
     
         11 . A compound as claimed in  claim 10  having formula VI (FIG. 1( g )) wherein M is selected from: 2H; Zn; Ni.  
     
     
         12 . A compound as claimed in any one of the preceding claims which has an absorption maximum in the near infra-red.  
     
     
         13 . A compound as claimed in any one of the preceding claims which is soluble.  
     
     
         14 . A composition comprising a compound as claimed any one of the preceding claims.  
     
     
         15 . A pharmaceutical composition comprising a compound of any one of  claims 1  to  13  in admixture with a pharmaceutically acceptable carrier.  
     
     
         16 . A compound of any one of  claims 1  to  13  for use in PDT.  
     
     
         17 . A compound of any one of  claims 1  to  13  for use in the preparation of a medicament.  
     
     
         18 . A compound as claimed in  claim 16  or  claim 17  wherein the PDT or the medicament is for the treatment of a mammal having a tumour susceptible to photodynamic treatment.  
     
     
         19 . A method of treatment comprising the step of exposing a compound as claimed in any one of  claims 1  to  13  to laser radiation.  
     
     
         20 . Use of a compound of any one of  claims 1  to  13  in an LC device.  
     
     
         21 . An LC device comprising two spaced walls each bearing electrode structures and treated on at least one facing surface with an alignment layer comprising a compound as claimed in any one of  claims 1  to  13 .  
     
     
         22 . An LC device as claimed in  claim 21  which is an electro-optical display device.  
     
     
         23 . Use of a compound of any one of  claims 1  to  13  in an optical recording medium.  
     
     
         24 . A method of storing or retrieving information comprising the step of exposing a compound as claimed in any one of  claims 1  to  13  to laser radiation.  
     
     
         25 . An optical recording medium comprising a recording layer, said layer comprising a compound as claimed in any one of  claims 1  to  13 .  
     
     
         26 . An optical recording medium as claimed  25  wherein the compound is present as a spin coated film.  
     
     
         27 . An optical recording medium as claimed in  claim 26  wherein the compound is a near infra-red absorber.  
     
     
         28 . Use of a compound of any one of  claims 1  to  13  in a gas sensor.  
     
     
         29 . A method of detecting a gas in a sample comprising the step of exposing a compound as claimed in any one of  claims 1  to  13  to the sample.  
     
     
         30 . A gas sensor comprising a compound as claimed in any one of  claims 1  to  13 .  
     
     
         31 . A gas sensor as claimed in  claim 30  wherein the compound is present as a spin coated film.  
     
     
         32 . An LB film comprising a compound as claimed in any one of  claims 1  to  13 .  
     
     
         33 . A molecular wire comprising a compound as claimed in any one  claims 1  to  13 .  
     
     
         34 . Use of a compound as claimed in any one of  claims 1  to  13  in a Photonic device.  
     
     
         35 . A Photonic device comprising a compound as claimed in any one of  claims 1  to  13 .  
     
     
         36 . Use of a compound as claimed in claimed in any one of  claims 1  to  13  in any one of the following: electrocatalysis; photocatalysis; electric conduction; photoconductivity: electrochromism; a photovoltaic cell; a battery.  
     
     
         37 . Use of a compound as claimed in any one of  claims 1  to  13  in the production of a dimer.  
     
     
         38 . A dimer or higher oligomer consisting of a compound as claimed in any one  claims 1  to  13 .  
     
     
         39 . A mixed dimer or higher oligomer comprising a compound as claimed in any one and a further Pc or Pc derivative.  
     
     
         40 . Use of a compound of any one of  claims 1  to  13  in the production of a polymer.  
     
     
         41 . A polymer consisting of a compound as claimed in any one of  claims 1  to  13  in polymerised form.  
     
     
         42 . An AzaPc essentially as described herein with reference to the accompanying Examples and Figures.  
     
     
         43 . A method of producing a compound as claimed in any one  claims 1  to  13  essentially as described herein with reference to Example 1.

Join the waitlist — get patent alerts

Track US2002128249A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.